Dolby Laboratories (DLB) FY2013 results: revenue $910 million, down 2.5% on the year
Dolby Laboratories, Inc. (DLB) reported revenue of $910 million for fiscal 2013, the year ended 27 September 2013, down 2.5% on the year before. Net income was $189 million, down 28.4%, and diluted earnings per share $1.84. The figures are the company's own, from the 10-K it filed with the SEC on 15 November 2013.
Revenue
$910 million
-2.5% on the year
FY2008FY2013
Operating margin
27.0%
38.8% a year earlier
FY2008FY2013
Net income
$189 million
-28.4% on the year
FY2008FY2013
Diluted EPS
$1.84
-25.2% on the year
FY2008FY2013
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Revenue
910
933
961
-2.5%
Cost of revenue
96.7
92.0
111
+5.1%
Gross profit
813
841
850
-3.3%
Gross margin
89.4%
90.1%
88.4%
Research and development
169
140
124
+20.4%
Operating income
245
362
430
-32.2%
Operating margin
27.0%
38.8%
44.7%
Interest expense
0.6
0.2
-1.0
+193.4%
Pre-tax income
251
369
441
-32.1%
Income tax
60.3
104
130
-41.9%
Effective tax rate
24.1%
28.1%
29.5%
Net income
189
264
309
-28.4%
Net margin
20.8%
28.3%
32.2%
Diluted EPS
$1.84
$2.46
$2.75
-25.2%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Operating cash flow
277
390
404
-29.1%
Capital expenditure
26.7
167
47.4
-84.0%
Free cash flow
250
222
356
+12.3%
Free cash flow margin
27.5%
23.8%
37.1%
Cash from investing
175
-195
-237
Cash from financing
-488
-254
-162
Depreciation and amortisation
53.2
43.9
44.0
+21.4%
Share-based compensation
64.3
47.6
43.7
+35.2%
Buybacks
82.2
268
192
-69.3%
Dividends paid
408
0.0
0.0
Dividend per share
$4.00
n/a
n/a
Diluted shares, weighted
103m
108m
113m
-4.4%
Balance sheet
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Shareholders' equity
1,481
1,720
1,664
-13.9%
Non-controlling interest
18.9
23.0
21.8
-17.6%
Debt
0.0
0.0
0.0
Other liabilities
238
218
199
+9.4%
Total liabilities and equity
1,738
1,961
1,884
-11.4%
Fixed assets
243
255
117
-4.6%
Goodwill
280
281
263
-0.6%
Intangible assets
41.3
56.5
51.6
-26.9%
Investments
447
664
664
-32.8%
Cash and equivalents
454
493
552
-7.8%
Receivables
97.5
43.5
61.8
+124.1%
Inventory
10.1
16.7
26.2
-39.6%
Other assets
165
151
149
+9.5%
Total assets
1,738
1,961
1,884
-11.4%
10-K for the year ended 27 September 2013, filed 15 November 2013: the filing.